Koninklijke DSM NV (KDSKF)
35.00
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 234.38M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -71.75% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 94.52% |
Profile
| Based in the Netherlands, Koninklijke DSM is a global science-based company operating in the fields of nutrition, health, and sustainable living. The company provides solutions for animal nutrition and feed, food & beverages, pharmaceuticals, medical nutrition, early life nutrition, nutrition improvement, dietary supplements, and personal care. DSM is active in all stages of the value chain, producing pure active ingredients, incorporating them into sophisticated forms, and providing tailored premixes, forward solutions, and branded consumer products. |
| URL | https://www.dsm.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Equity Style | Large Cap/Growth |
| Next Earnings Release | May. 14, 2024 (est.) |
| Last Earnings Release | Feb. 16, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 04, 2022 |
Ratings
Profile
| Based in the Netherlands, Koninklijke DSM is a global science-based company operating in the fields of nutrition, health, and sustainable living. The company provides solutions for animal nutrition and feed, food & beverages, pharmaceuticals, medical nutrition, early life nutrition, nutrition improvement, dietary supplements, and personal care. DSM is active in all stages of the value chain, producing pure active ingredients, incorporating them into sophisticated forms, and providing tailored premixes, forward solutions, and branded consumer products. |
| URL | https://www.dsm.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Equity Style | Large Cap/Growth |
| Next Earnings Release | May. 14, 2024 (est.) |
| Last Earnings Release | Feb. 16, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 04, 2022 |